Drugs for Body Mass Index Quantitative Trait Locus 9 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 944)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Dalteparin |
Approved |
Phase 4 |
|
9005-49-6 |
|
Synonyms:
|
2 |
|
Clarithromycin |
Approved |
Phase 4 |
|
81103-11-9 |
84029 |
Synonyms:
(14R)-14-Hydroxyclarithromycin
116836-41-0
6-O-methyl erythromycin
6-O-methylerythromycin
6-O-Methylerythromycin
6-O-methylerythromycin A
6-O-Methylerythromycin a
81103-11-9
A-56268
Abbotic
Abbott-56268
AC1L1HJO
AC1L36NJ
AC1NFSZE
AC1NR4MY
AC1NSJWH
AC1O52DV
AC1Q6O1T
AC-6813
Adel
ANX-015
Astromen
BB_NC-1450
Biaxin
Biaxin (TN)
Biaxin filmtab
Biaxin HP
Biaxin XL
Biaxin xl filmtab
Bicrolid
BIDD:GT0200
Bio-0020
BSPBio_003453
C06912
C2220
C30H54O11.C9H19NO2
CAM
CCRIS 8833
CHEBI:136451
CHEBI:3732
CHEMBL143
CHEMBL1741
CID10147055
CID10328822
CID11814635
CID11828745
CID11969952
CID4663848
CID489010
CID5284534
CID5311050
CID54688
CID6426662
CID84029
CID9810688
CID9811194
CLA
Clacine
Clambiotic
Claribid
Claricide
Clarith
clarithromycin
Clarithromycin
Clarithromycin & Interleukin-12
Clarithromycin (JP15/USP/INN)
Clarithromycin [USAN:INN:BAN:JAN]
Clarithromycin extended release
Clarithromycin suspension or tablets
clarithromycina
Clarithromycina
Clarithromycine
Clarithromycine [INN-French]
Clarithromycinum
Clarithromycinum [INN-Latin]
|
Claritromicina
Claritromicina [INN-Spanish]
Clathromycin
CLM & IL-12
CPD000466382
CRL-1605 & Clarithromycin
CTY
Cyllid
Cyllind
D00276
DivK1c_006655
DRG-0099
Helas
Heliclar
HMS1922H09
HMS2051G18
HMS2090O11
HMS2094M05
hydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexame
I05-0074
KBio1_001599
KBio2_000509
KBio2_003077
KBio2_005645
KBio3_002673
KBioGR_001218
KBioSS_000509
Klacid
Klaciped
Klaricid
Klaricid H.P
Klaricid H.P.
Klaricid Pediatric
Klaricid XL
Klarid
Klarin
Klax
Kofron
Lactoferrin B & Clarithromycin
Lactoferrin H & Clarithromycin
LMPK04000014
LS-1812
Mabicrol
Macladin
Maclar
Mavid
MLS000759516
MLS001201751
MLS001424066
MolPort-002-507-425
MolPort-003-845-969
MolPort-005-910-192
MolPort-005-934-146
Naxy
NCGC00178054-01
NSC643733
O(6)-methylerythromycin
SAM001246748
SDP-015
SMR000466382
SPBio_001855
SpecPlus_000559
Spectrum_000089
SPECTRUM1504231
Spectrum2_001668
Spectrum3_001667
Spectrum4_000629
Spectrum5_001729
STK801952
TE031
TE-031
UNII-H1250JIK0A
Veclam
Zeclar
|
|
3 |
|
Bismuth subsalicylate |
Approved, Vet_approved |
Phase 4 |
|
14882-18-9 |
53629521 |
Synonyms:
2-Hydroxy-benzo[1,3,2]dioxabismin-4-one
Basic bismuth salicylate
Basic bismuth salicylic acid
Bismuth
Bismuth oxide salicylate
Bismuth oxide salicylic acid
Bismuth oxysalicylate
Bismuth oxysalicylic acid
Bismuth Subsalicylate
Bismuth subsalicylic acid
|
Bismuth(III) subsalicylate
Bismuthi subsalicylas
Bismutum subsalicylicum
Helidac
Kaopectate
Pepto-bismol
Pink bismuth
Subsalicylate bismuth
Trigastronol
Wismutsubsalicylat
|
|
4 |
|
Clopidogrel |
Approved |
Phase 4 |
|
120202-66-6, 113665-84-2 |
60606 |
Synonyms:
( )-(S)-Clopidogrel
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
113665-84-2
AC-19024
AC1L1TKZ
AC1Q41I9
BIDD:GT0284
BMS Brand 1 OF clopidogrel bisulfate
BMS Brand 2 OF clopidogrel bisulfate
BRD-K27721098-065-02-9
BSPBio_003211
C16H16ClNO2S
CGE
CHEBI:37941
CHEMBL1771
CID60606
clopidogrel
Clopidogrel
Clopidogrel (INN)
Clopidogrel (TN)
Clopidogrel [Ban:Inn]
Clopidogrel [BAN:INN]
Clopidogrel [INN:BAN]
Clopidogrel besilate
Clopidogrel besylate
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel hydrochloride
Clopidogrel mepha
Clopidogrel napadisilate
Clopidogrel sandoz
Clopidogrel sulfate
CLOPIDOGREL SULFATE
clopidogrel, (+)(S)-isomer
Clopidogrel, (+)(S)-isomer
Clopidogrel-mepha
Clopidogrelum
CPD000550475
D07729
|
DB00758
DivK1c_000787
HMS2090O21
HMS502H09
HSDB 7430
IDI1_000787
Iscover
Isocover
KBio1_000787
KBio2_000545
KBio2_003113
KBio2_005681
KBio3_002431
KBioGR_000689
KBioSS_000545
LS-172232
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
MLS001165708
MLS001195633
MLS001304711
MolPort-002-885-817
MolPort-003-845-991
NCGC00163329-02
nchem.651-comp8
NINDS_000787
Plavix
Plavix (TN)
SAM002589956
SMR000550475
SPBio_000463
Spectrum_000105
Spectrum2_000512
Spectrum3_001606
Spectrum4_000175
SR 25990
STK580572
STOCK5S-27782
TL8000400
UNII-A74586SNO7
Zyllt
|
|
5 |
|
Ticagrelor |
Approved |
Phase 4 |
|
274693-27-5 |
9871419 |
Synonyms:
(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-D)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
3-(7-((2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-(1-3)-triazolo(4,5-D)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
AZD 6140
AZD6140
|
AZD-6140
Brilinta
Brilique
Ticagrelor
|
|
6 |
|
Cilostazol |
Approved, Investigational |
Phase 4 |
|
73963-72-1 |
2754 |
Synonyms:
3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone
6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one
6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one
73963-72-1
89332-50-3
AC1L1EE2
AC-4334
BRD-K67017579-001-04-2
BRD-K67017579-001-05-9
BRD-K67017579-001-07-5
BRD-K67017579-001-13-3
BRN 3632107
BSPBio_002759
C 0737
C045645
C0737_SIGMA
C20H27N5O2
CHEBI:31401
CHEMBL799
CID2754
cilostazol
Cilostazol
Cilostazol (JP15/USAN/INN)
Cilostazol [INN:JAN]
Cilostazole
Cilostazolum
Cilostazolum [INN-Latin]
CL23867
CPD000058428
D01896
DB01166
EU-0100218
HMS1922N15
HMS2093M14
KBio3_002259
|
KBioGR_001184
Lopac0_000218
Lopac-C-0737
LS-142693
MLS000028470
MLS000758281
MLS000759507
MLS001076067
MLS002153891
MolPort-001-758-007
NCGC00015207-01
NCGC00015207-02
NCGC00015207-06
NCGC00015207-10
NCGC00022153-02
NCGC00022153-04
NCGC00022153-05
NCGC00022153-06
NCGC00022153-07
OPC 13013
OPC 21
OPC-13013
OPC-21
Otsuka brand of cilostazol
Pletaal
Pletal
Pletal (TN)
Pletal, Cilostazol
S1294_Selleck
SAM001246734
SAM001247085
SMR000058428
SPBio_001256
SPECTRUM1505230
Spectrum2_001118
Spectrum3_001170
Spectrum4_000772
Spectrum5_001762
TL8005113
Tocris-1692
UNII-N7Z035406B
ZINC01552174
|
|
7 |
|
Dexlansoprazole |
Approved, Investigational |
Phase 4 |
|
138530-94-6, 103577-45-3 |
9578005 |
Synonyms:
138530-94-6
2-((R)-((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
CHEMBL1201863
CID9578005
D08903
dexlansoprazole
Dexlansoprazole
Dexlansoprazole (INN/USAN)
|
Kapidex
KS-1075
MolPort-002-885-834
T 168390
TAK 390
UNII-UYE4T5I70X
ZINC00599734
|
|
8 |
|
Lansoprazole |
Approved, Investigational |
Phase 4 |
|
103577-45-3 |
3883 |
Synonyms:
103577-45-3
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
A 65006
A-65006
AB00052388
Abbot brand OF lansoprazole
Abbot Brand of Lansoprazole
ABT-006
AC1L1GX8
AG 1749
AG-1749
Agopton
Almirall brand OF lansoprazole
Almirall Brand of Lansoprazole
Amarin
Aprazol
Bamalite
BIDD:GT0006
Bio-0824
Biuret
Biuret Gr
Biuret Reagent
Biuret Reagent Solution
Blason
BPBio1_001194
BRD-A49172652-001-05-7
BRN 4333393
BSPBio_001084
BSPBio_001830
C058687
C16H14F3N3O2S
CAS-103577-45-3
CG-4801
CHEBI:6375
CHEMBL480
CID3883
Compraz
CPD000058469
D00355
Dakar
DB00448
DivK1c_000920
EU-0100709
FT-0082011
HMS1571G06
HMS1922M04
HMS2052F05
HMS2093M07
HMS502N22
Hoechst brand OF lansoprazole
Hoechst Brand of Lansoprazole
Hormona brand OF lansoprazole
Hormona Brand of Lansoprazole
HSDB 7204
I06-0018
IDI1_000920
Ilsatec
KBio1_000920
KBio2_002060
KBio2_004628
KBio2_007196
KBio3_001330
KBioGR_001491
KBioSS_002060
Ketian
L 8533
L8533_SIGMA
Lancid
Lanfast
Lanproton
Lansol
Lansopep
Lansophed
Lansoprazol
Lansoprazol [INN-Spanish]
lansoprazole
Lansoprazole
Lansoprazole (JAN/USP/INN)
Lansoprazole [Usan:Ban:Inn]
Lansoprazole [USAN:BAN:INN]
Lansoprazole abbot brand
Lansoprazole almirall brand
Lansoprazole hoechst brand
Lansoprazole hormona brand
Lansoprazole lederle brand
Lansoprazole promeco brand
Lansoprazole salvar brand
Lansoprazole sodium
lansoprazole sulphone
Lansoprazole takeda brand
Lansoprazole tap brand
Lansoprazole tecnobio brand
Lansoprazole vinas brand
Lansoprazole wyeth brand
|
Lansoprazoles
Lansoprazolum
Lansoprazolum [INN-Latin]
Lansox
Lanston
Lanz
Lanzo
Lanzol
Lanzol-30
Lanzopral
lanzoprazole
Lanzor
Lanzul
Lapraz
Lasoprol
Lederle brand OF lansoprazole
Lederle Brand of Lansoprazole
Limpidex
Linamarin
Lopac0_000709
Lopac-L-8533
LS-33080
Mesactol
MLS000069705
MLS-0003247.0001
MLS000759405
MLS001074170
MolPort-003-666-508
MolPort-006-394-760
Monolitum
NCGC00015615-01
NCGC00015615-02
NCGC00015615-03
NCGC00015615-06
NCGC00015615-11
NCGC00023826-03
NCGC00023826-04
NCGC00023826-05
NCGC00023826-06
NCGC00023826-07
NINDS_000920
Ogast
Ogastro
Opiren
Prestwick0_001072
Prestwick1_001072
Prestwick2_001072
Prestwick3_001072
Prevacid
Prevacid (TN)
Prevacid I.V
Prevacid I.V.
Prevacid Iv
Prevacid Solutab
Prevacid SoluTab
Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole
PrevOnco
Prevpac
Prezal
Pro ulco
Pro Ulco
Promeco
Promeco brand OF lansoprazole
Promeco Brand of Lansoprazole
Promp
Prosogan
S1354_Selleck
Salvar brand OF lansoprazole
Salvar Brand of Lansoprazole
SAM001246544
SMR000058469
Sodium, lansoprazole
SPBio_000488
SPBio_002992
Spectrum_001580
SPECTRUM1503926
Spectrum2_000444
Spectrum3_000295
Spectrum4_000856
Spectrum5_001521
STK621169
Suprecid
TAK 390MR
TAK390MR
TAK-390MR
Takeda brand OF lansoprazole
Takeda Brand of Lansoprazole
Takepron
TAP brand OF lansoprazole
TAP Brand of Lansoprazole
Tecnobio brand OF lansoprazole
Tecnobio Brand of Lansoprazole
TL8000155
Ulpax
UNII-0K5C5T2QPG
Vinas brand OF lansoprazole
Vinas Brand of Lansoprazole
Wyeth brand OF lansoprazole
Wyeth Brand of Lansoprazole
Zoprol
Zoton
|
|
9 |
|
Linagliptin |
Approved |
Phase 4 |
|
668270-12-0 |
10096344 |
Synonyms:
(R)-8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
668270-12-0
BI 1356
BI-1356
BI-1356-BS
CHEBI:49403
|
CHEBI:499873
CHEMBL237500
CID 10096344
CID10096344
Linagliptin
Linagliptina
Ondero
|
|
10 |
|
Indapamide |
Approved |
Phase 4 |
|
26807-65-8 |
3702 |
Synonyms:
1-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline
26807-65-8
3-(Aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide
49564-58-1
4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide
4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide
5-20-06-00348 (Beilstein Handbook Reference)
AB00052021
AC1L1GIW
AC-2073
Apo-Indapamide
Arifon
Bajaten
Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)- (9CI)
BPBio1_000263
BRD-A95869247-001-04-6
BRN 1604026
BSPBio_000239
BSPBio_002174
CHEMBL406
CID3702
Cormil
CPD000058829
D00345
Damide
DB00808
DivK1c_000508
EINECS 248-012-7
Fludex
HMS1920F19
HMS2090M16
HMS2091N07
HMS501J10
I01-0369
I0730
I1887_FLUKA
I1887_SIGMA
Idapamide
IDI1_000508
Indaflex
Indamol
Indapamid
Indapamida
Indapamida [INN-Spanish]
indapamide
Indapamide
Indapamide (JAN/USP)
Indapamide (USP)
Indapamide [USAN:INN:BAN:JAN]
Indapamidum
Indapamidum [INN-Latin]
Ipamix
|
KBio1_000508
KBio2_001397
KBio2_003965
KBio2_006533
KBio3_001394
KBioGR_000393
KBioSS_001397
Lozide
Lozol
Lozol (TN)
LS-26138
Metindamide
MLS000028554
MLS001148152
MLS002222229
MolPort-003-666-209
N-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline
N-[4-Chloro-3-sulfamoylbenzamido]-2- methylindoline
Natrilix
Natrix
Natrix (TN)
NCGC00089727-02
NCGC00089727-03
NINDS_000508
NLozol, Arifon, Fludex, Noranat, Veroxil, Tertensif, Indapamide
Noranat
Novo-Indapamide
Nu-Indapamide
Pressurai
Prestwick3_000220
RHC 2555
S-1520
S1730_Selleck
SAM002564214
SE 1520
SE-1520
SMR000058829
SPBio_001019
Spectrum_000917
SPECTRUM1500349
Spectrum2_000980
Spectrum3_000467
Spectrum4_000017
Spectrum5_000866
ST51015024
Tandix
Tertensif
TL8002131
UNII-F089I0511L
USV 2555
Veroxil
|
|
11 |
|
Celecoxib |
Approved, Investigational |
Phase 4 |
|
169590-42-5 |
2662 |
Synonyms:
169590-42-5
184007-95-2
1oq5
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
AC1L1E6K
AC-4228
AI-525
Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)
BIDD:GT0408
BRD-K02637541-001-02-4
BSPBio_003596
C07589
C105934
C17H14F3N3O2S
CCRIS 8679
CEL
Celebra
Celebrex
Celebrex (TN)
Celebrex, Celebra, Celecoxib
Celecox
Celecoxi
celecoxib
Celecoxib
Célécoxib
Celecoxib (JAN/USAN/INN)
Celecoxib (SC-58635)
Celecoxib [Old RN]
Celecoxib [USAN]
Celecoxibum
Celocoxib
CEP-33222
CHEBI:41423
CHEMBL118
CID2662
cMAP_000027
CPD000550473
D00567
DB00482
DivK1c_000893
Eurocox
FT-0080064
HMS1922G14
HMS2089L18
HMS2093I07
HMS502M15
HSDB 7038
I01-1033
IDI1_000893
KBio1_000893
|
KBio2_000912
KBio2_002351
KBio2_003480
KBio2_004919
KBio2_006048
KBio2_007487
KBio3_002830
KBio3_003037
KBioGR_000723
KBioGR_002351
KBioSS_000912
KBioSS_002354
LS-31667
Medicoxib
MLS001165684
MLS001195656
MLS001304708
MolPort-002-885-815
NCGC00091455-01
NCGC00091455-02
NCGC00091455-03
NCGC00091455-04
NCI60_041049
NINDS_000893
NSC719627
Onsenal
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulphonamide
Pfizer brand of celecoxib
S1261_Selleck
SAM002589995
SC 58635
SC-58553, SC-58635
SC58635
SC-58635
SMR000550473
Solexa
SPBio_001512
Spectrum_000432
SPECTRUM1503678
Spectrum2_001576
Spectrum3_001996
Spectrum4_000182
Spectrum5_001324
TL8001323
TPI-336
UNM-0000305813
Xilebao
YM 177
YM177
YM-177
ZINC02570895
|
|
12 |
|
Linezolid |
Approved, Investigational |
Phase 4 |
|
165800-03-3 |
441401 |
Synonyms:
(S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide
111GE017
165800-03-3
AC-16128
AC1L9B3M
BIDD:GT0404
C08146
C16H20FN3O4
CHEBI:126280
CHEMBL126
CID441401
CPD000466335
D00947
DB00601
DB08769
FT-0080803
HMS2051F08
HMS2089K06
HSDB 7478
Linezlid
linezolid
Linezolid
Linezolid & VRC3375
Linezolid (JAN/USAN/INN)
Linezolid [USAN:INN]
Linezolide
Linezolidum
LS-173594
|
MLS000759444
MLS001424075
MolPort-003-986-503
N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
N-((3-(3-Fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
N-({5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide, N-[[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide
N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
NDA 21-130 Zyvox (linezolid tablets)
NDA 21-131 Zyvox for injection (linezolid injection)
NDA 21-132 Zyvox oral suspension (linzolid oral suspension)
PNU 100766
PNU-100766
PNU-100766, U-100766, Zyvoxid, Zyvoxam, Linezolid
S1408_Selleck
SAM001246624
SMR000466335
TL8001272
U 100766
U-100766
ZINC02008866
ZLD
Zyvox
Zyvox (TN)
Zyvoxa
Zyvoxam
Zyvoxid
|
|
13 |
|
Metyrapone |
Approved, Investigational |
Phase 4 |
|
54-36-4 |
4174 |
Synonyms:
1,2-Di-3-pyridyl-2-methyl-1-propanone
2-Methyl-1,2-bis(3-pyridyl)-1-propanone
2-Methyl-1,2-di-3-pyridinyl-1-propanone
2-Methyl-1,2-di-3-pyridyl-1-propanone
2-methyl-1,2-dipyridin-3-ylpropan-1-one
2-methyl-1,2-dipyridin-3-yl-propan-1-one
37245-80-0
4885, SU
54-36-4
856525_ALDRICH
AB00513955
AC1L1HKV
AC1Q1LHX
Alliance brand OF metyrapone
Alliance Brand of Metyrapone
BIDD:PXR0082
BPBio1_000824
BRD-K46862739-001-03-6
BSPBio_000748
C07205
C14H14N2O
CAS-54-36-4
CHEBI:44241
CHEMBL934
CID4174
CPD000059134
CPD-7023
D00410
D008797
DB01011
EINECS 200-206-2
EU-0009322
HMS1570F10
HMS2094I07
HSDB 2500
LS-123097
Mepyrapone
Metapirone
Metapyron
Methapyrapone
Methbipyranone
Methopirapone
Methopyrapone
Methopyrinine
|
Methopyrone
Metirapona
Metirapona [INN-Spanish]
Metopiron
Metopirone
Métopirone
METOPIRONE (TN)
Metopyrone
Metroprione
Metyrapon
metyrapone
Metyrapone
Métyrapone
Metyrapone (JP15/USP/INN)
Metyrapone [USAN:INN:BAN:JAN]
Metyrapone alliance brand
Metyrapone Alliance Brand
Metyrapone novartis brand
Metyrapone Novartis Brand
Metyraponum
Metyraponum [INN-Latin]
MLS001066377
MLS001335881
MLS001335882
MolPort-001-794-644
MYT
NCGC00016242-01
NCGC00161837-01
Novartis brand OF metyrapone
Novartis Brand of Metyrapone
NSC 25265
NSC25265
Prestwick0_000904
Prestwick1_000904
Prestwick2_000904
Prestwick3_000904
SAM002297829
SMR000059134
SPBio_002947
ST51006925
Su 4885
Su-4885
UNII-ZS9KD92H6V
ZINC00001728
|
|
14 |
|
Tolnaftate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
2398-96-1 |
5510 |
Synonyms:
2398-96-1
2-Naphthyl N-methyl-N-(3-tolyl)thionocarbamate
2-Naphthyl N-methyl-N-(3-tolyl)thionocarbamic acid
94256-64-1
AB00052111
AC1L1KI4
AC-5548
Aftate
Aftate for athlete's foot aerosol spray liquid
Aftate for athlete's foot aerosol spray powder
Aftate for athlete's foot gel
Aftate for athlete's foot sprinkle powder
Aftate for jock itch aerosol spray powder
Aftate for jock itch gel
Aftate for jock itch sprinkle powder
AKOS005111014
Bioglan brand OF tolnaftate
Bioglan Brand of Tolnaftate
BPBio1_000285
BRD-K44273375-001-04-5
Breezee
BRN 2752620
BSPBio_000259
C19H17NOS
Carbamothioic acid, methyl(3-methylphenyl)-, O-2-naphthalenyl ester
Carbamothioic acid, N-methyl-N-(3-methylphenyl)-, O-2-naphthalenyl ester
Carbanilic acid, m,N-dimethylthio-, O-2-naphthyl ester
Carbanilic acid, N,m-dimethylthio-, O-2-naphthyl ester
Carter wallace brand OF tolnaftate
Carter Wallace Brand of Tolnaftate
CAS-2398-96-1
CHEMBL83668
Chinofungin
Chinosol brand OF tolnaftate
Chinosol Brand of Tolnaftate
Chlorisept
CID5510
Curatin
D00381
D014047
DB00525
Dermoxin
DivK1c_000334
Douglas brand OF tolnaftate
Douglas Brand of Tolnaftate
Dr. scholl's athlete's foot spray
Dr. Scholl's athlete's foot spray
Dungistop
EINECS 219-266-6
Essex brand OF tolnaftate
Essex Brand of Tolnaftate
Focusan
Fungistop
Genaspor
Genaspore cream
Hi-alarzin
Hi-alazin
HI-Alazin
HMS1568M21
HMS1921E21
HMS2092O05
HMS501A16
IDI1_000334
Insight brand OF tolnaftate
Insight Brand of Tolnaftate
Isdin brand OF tolnaftate
Isdin Brand of Tolnaftate
KBio1_000334
KBio2_001443
KBio2_004011
KBio2_006579
KBioGR_000799
KBioSS_001443
LS-51199
m,N-Dimethylthiocarbanilate O-2-naphthyl ester
m,N-Dimethylthiocarbanilic acid O-2-naphthyl ester
Methyl (3-methylphenyl)carbamothioate O-2-naphthalenyl ester
Methyl (3-methylphenyl)carbamothioic acid O-2-naphthalenyl ester
Methyl-(3-methylphenyl)carbamothioic acid O-2-naphthyl ester
Methyl-[3-methylphenyl]-carbamothioic acid O-2-naphthyl ester
Micoisdin
MLS000028526
MLS001146910
MolPort-002-893-958
Naphthiomate T
Naphthiomate-T
NCGC00016610-01
NCGC00016610-02
NCGC00023506-03
NINDS_000334
N-Methyl-(3-methylphenyl)-carbamothioic acid, O-2-naphthalenyl ester
N-methyl-N-(3-methylphenyl)-1-(naphthalen-2-yloxy)methanethioamide
N-Methyl-N-(3-methylphenyl)-1-(naphthalen-2-yloxy)methanethioamide
NP 27
NP27
NP-27
NP-27 Cream
NP-27 Powder
NP-27 Solution
NP-27 Spray powder
NP-27 Spray Powder
NSC 233648
NSC233648
o-(2-Naphthyl) methyl(3-methylphenyl)thiocarbamate
O-2-Naphthyl m,N-dimethylthiocarbanilate
O-2-Naphthyl m,N-dimethylthiocarbanilic acid
O-2-Naphthyl N,N-dimethylthiocarbanilate
O-naphthalen-2-yl methyl(3-methylphenyl)carbamothioate
|
O-naphthalen-2-yl N-methyl-N-(3-methylphenyl)carbamothioate
Ony clear
Ony Clear
Ony-clear
Ony-Clear
Pedinol brand 1 OF tolnaftate
Pedinol Brand 1 of Tolnaftate
Pedinol brand 2 OF tolnaftate
Pedinol Brand 2 of Tolnaftate
Phytoderm
Pitrex
Pitrex cream
Prestwick_472
Prestwick0_000070
Prestwick1_000070
Prestwick2_000070
Prestwick3_000070
Purder N, tolnaftat
Purder N, Tolnaftat
Sch 10144
Schering brand OF tolnaftate
Schering Brand of Tolnaftate
Schering-plough brand 1 OF tolnaftate
Schering-Plough Brand 1 of Tolnaftate
Schering-plough brand 2 OF tolnaftate
Schering-Plough Brand 2 of Tolnaftate
Separin
Separin (TN)
SMR000058288
Sorgoa
SPBio_000920
SPBio_002180
Spectrum_000963
SPECTRUM1500583
Spectrum2_000950
Spectrum4_000360
Spectrum5_001000
Sporiline
ST51015151
Stiefel brand OF tolnaftate
Stiefel Brand of Tolnaftate
STL069548
T6638_SIGMA
Thompson brand OF tolnaftate
Thompson Brand of Tolnaftate
Timoped
Tinactin
Tinactin (TN)
Tinactin aerosol liquid
Tinactin aerosol powder
Tinactin antifungal deodorant powder aerosol
Tinactin cream
Tinactin jock itch aerosol powder
Tinactin jock itch cream
Tinactin jock itch spray powder
Tinactin plus aerosol powder
Tinactin plus powder
Tinactin powder
Tinactin solution
Tinaderm
Tinatox
Tinavet
Tinavet (Veterinary)
Tineafax
Ting
Ting antifungal cream
Ting antifungal powder
Ting antifungal spray liquid
Ting antifungal spray powder
Ting products
Ting Products
Tniaderm
Tolnaftat purder N
Tolnaftat Purder N
tolnaftate
Tolnaftate
Tolnaftate (JP14/USP)
Tolnaftate (JP15/USP)
Tolnaftate (JP15/USP/INN)
Tolnaftate [USAN:BAN:INN:JAN]
Tolnaftate [USAN:INN:BAN:JAN]
Tolnaftate douglas brand
Tolnaftate Douglas Brand
Tolnaftate schering brand
Tolnaftate Schering Brand
Tolnaftate(USAN)
Tolnaftato
Tolnaftato [DCIT]
Tolnaftato [INN-Spanish]
Tolnaftatum
Tolnaftatum [INN-Latin]
Tolnaftic acid
Tolnaphthate
Tolnaphthic acid
Tolsanil
Tonoftal
Tritin
UNII-06KB629TKV
Wernigerode brand OF tolnaftate
Wernigerode Brand of Tolnaftate
ZeaSorb
Zeasorb-af
Zeasorb-af powder
Zeasorb-AF powder
Zenith brand OF tolnaftate
Zenith Brand of Tolnaftate
ZINC00057522
|
|
15 |
|
Orlistat |
Approved, Investigational |
Phase 4 |
|
96829-58-2 |
3034010 |
Synonyms:
(-)-Tetrahydrolipostatin
(-)-Tetrahydrolipstatin
(2S)-2-Formamido-4-methylpentanoate [(2S)-1-[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]tridecan-2-yl] ester
(2S)-2-Formamido-4-methylpentanoic acid [(2S)-1-[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]tridecan-2-yl] ester
[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate
1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate
1-((3-Hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate
111397-16-1
96829-58-2
AC-19012
AC1MHWQP
Alli
Alli, Xenical, Tetrahydrolipstatin, Orlistat
BIDD:GT0853
C055122
C29H53NO5
CHEMBL175247
CID3034010
CPD000466339
D04028
DB01083
FT-0082584
GlaxoSmithKline brand of orlistat
GlaxoSmithKline brand OF orlistat
HMS2051I08
Hoffmann-la roche brand OF orlistat
Hoffmann-La Roche brand of orlistat
KS-1183
L-Leucine, N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester
L-Leucine,N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester
LS-178328
MLS000759448
|
MLS001423955
MLS002207022
MolPort-005-938-035
NCGC00165856-01
nchembio.129-comp24
N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
N-Formyl-L-leucine (1S)-1-{[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl}dodecyl ester
N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone
O4139_SIGMA
Orlipastat
Orlipastatum
Orlipastatum [INN-Latin]
orlistat
Orlistat
Orlistat (USAN/INN)
Orlistat [USAN:INN]
Orlistatum
R-212
Ro 18-0647/002
Ro 18-0647/008
Ro-18-0647
Roche brand of orlistat
Roche brand OF orlistat
S1629_Selleck
SAM001246637
SMR000466339
Tetrahydrolipastatin
Tetrahydrolipstatin
THLP
UNII-95M8R751W8
Xenical
Xenical (TN)
|
|
16 |
|
Zonisamide |
Approved, Investigational |
Phase 4 |
|
68291-97-4 |
5734 |
Synonyms:
1-(1,2-benzisoxazol-3-yl)methanesulfonamide
1-(1,2-Benzoxazol-3-Yl)methanesulfonamide
1,2-Benzisoxazole-3-methanesulfonamide
1,2-Benzisoxazole-3-methanesulphonamide
1,2-benzoxazol-3-ylmethanesulfonamide
3 Sulfamoylmethyl 1,2 benzisoxazole
3-(Sulfamoylmethyl)-1,2-benzisoxazole
3-(Sulphamoylmethyl)-1,2-benzisoxazole
3-sulfamoylmethyl-1,2-benzisoxazole
3-Sulfamoylmethyl-1,2-benzisoxazole
68291-97-4
AC-1413
AC1L1L0Q
AC1Q55GQ
AD 810
AD-810
AD-810N
AKOS001312269
Benzo[d]isoxazol-3-yl-methanesulfonamide
Benzo[D]isoxazol-3-yl-methanesulfonamide
Benzo[D]isoxazol-3-yl-methanesulphonamide
BIDD:GT0708
BIDD:PXR0183
Bio-0532
BRD-K48300629-001-03-8
BRN 1077076
C022189
C07504
C8H8N2O3S
CHEBI:10127
CHEMBL750
CI 912
CI-912
CID5734
CPD000596519
D00538
DB00909
E-2090
Elan brand of zonisamide
|
Elan brand OF zonisamide
Exceglan
Excegram
Excegran
Excegran (TN)
FT-0082702
HMS2089O07
HSDB 7293
I06-0495
LS-33637
MLS001195632
MLS001306491
MolPort-002-507-855
NCGC00159319-02
NCGC00159319-03
PD 110843
PD-110843
S1445_Selleck
SAM002548957
SMR000596519
SPR_2
STK711131
Tremode
Trerief
UNII-459384H98V
ZINC00004321
Zonegran
Zonegran, Zonisamide
Zonisamida
Zonisamida [Spanish]
zonisamide
Zonisamide
Zonisamide (JAN/USAN/INN)
Zonisamide (ZNS)
Zonisamide [USAN:BAN:INN:JAN]
zonisamide monosodium
Zonisamide monosodium
Zonisamidum
Zonisamidum [Latin]
|
|
17 |
|
Chlorhexidine |
Approved, Vet_approved |
Phase 4 |
|
55-56-1 |
9552079 2713 |
Synonyms:
1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide]
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide
1,6-Bis(5-(p-chlorophenyl)biguandino)hexane
1,6-Bis(p-chlorophenyldiguanido)hexane
1,6-Di(4'-chlorophenyldiguanido)hexane
1,6-Di(N-p-chlorophenyldiguanido)hexane
24798_FLUKA
282227_ALDRICH
348031_ALDRICH
4-12-00-01201 (Beilstein Handbook Reference)
55-56-1
AB00053427
AB1003159
AVAGARD
BPBio1_000272
BRN 2826432
BSPBio_000246
BSPBio_001977
C06902
C22H30Cl2N10
CAS-55-56-1
CCRIS 9230
CHEBI:3614
CHEMBL790
Chlorhexidin
Chlorhexidin [Czech]
chlorhexidine
Chlorhexidine
Chlorhexidine (INN)
Chlorhexidine [INN:BAN]
Chlorhexidine Base
Chlorhexidine gluconate
Chlorhexidinum
Chlorhexidinum [INN-Latin]
CID9552079
Cloresidina
Cloresidina [DCIT]
Clorhexidina
Clorhexidina [INN-Spanish]
D07668
DB00878
Decanoylacetaldehyde Sodium Sulfide
Dentisept
Dentisept [veterinary]
Dentisept [veterinary] (TN)
DivK1c_000761
EINECS 200-238-7
Fimeil
Hexadol
Hibiclens
Hibispray
Hibistat
HMS1568M08
HSDB 7196
I06-0621
I14-0050
IDI1_000761
|
KBio1_000761
KBio2_000717
KBio2_003285
KBio2_005853
KBio3_001197
KBioGR_000774
KBioSS_000717
Lisium (*Dihydrochloride*)
LS-43917
Merfen-incolore
Merfen-incolore (TN)
MK-412A
MLS001332387
MLS001332388
MLS002154209
MolPort-002-541-741
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]
NCGC00016246-01
NCGC00091025-01
NCGC00091025-02
NINDS_000761
Nolvasan
Nolvasan (*Diacetate*)
Novalsan
NSC526936
Oro-Clense
Peridex
Periogard
Prestwick_53
Prestwick0_000143
Prestwick1_000143
Prestwick2_000143
Prestwick3_000143
QTL1_000020
Rotersept
Savloclens
Savlon babycare
Sebidin A
SMR000857146
Sodium Houttuyfonamide
Soretol
SPBio_000210
SPBio_002185
Spectrum_000237
Spectrum2_000135
Spectrum3_000339
Spectrum4_000277
Spectrum5_001322
Sterido
Sterilon
STK089248
STOCK1S-18831
Superspray
Tubulicid
UNII-R4KO0DY52L
|
|
18 |
|
Aripiprazole |
Approved, Investigational |
Phase 4 |
|
129722-12-9 |
60795 |
Synonyms:
||OPC 14597
129722-12-9
24-29-3
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one
Abilify
Abilify (TN)
Abilify Discmelt
Abilitat
AC-1554
AC1L1TXZ
AC1Q3T38
ALKS-9070
aripiprazol
Aripiprazol
aripiprazole
Aripiprazole
Aripiprazole (JAN/USAN/INN)
Aripiprazole [USAN]
aripiprazolum
Aripiprazolum
Aripirazole
Arpizol
Asprito|
Bio-0004
BMS-337039
Bristol-Myers Squibb brand of aripiprazole
C094645
C12564
C23H27Cl2N3O2
CHEBI:31236
|
CHEMBL1112
CID60795
CPD000466383
D01164
DB01238
Discmelt
FT-0082572
HMS2051I18
HMS2089M20
HMS2093F22
HSDB 7320
KS-1030
L001339
LS-142666
MLS000759517
MLS001165779
MLS001195621
MLS001424078
MolPort-002-885-808
MolPort-003-844-657
NCGC00159510-02
NCGC00159510-03
Opc 14597
OPC 31
OPC-14597
OPC-31
Otsuka brand of aripiprazole
Pripiprazole
S06-0010
SAM001246750
SMR000466383
STK625160
TL8000707
TL80090184
UNII-82VFR53I78
|
|
19 |
|
Ziprasidone |
Approved |
Phase 4 |
|
146939-27-7 |
60854 |
Synonyms:
138982-67-9 (hydrochloride monohydrate)
146939-27-7
5-(2-(4-(3-Benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
6-chloro-5-[2-[4-(7-thia-8-azabicyclo[4.3.0]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one
AC1L1U27
Ambap122883-93-6
BIDD:GT0042
C07568
C21H21ClN4OS
CHEBI:10119
CHEMBL708
CID60854
CP 88059
CP 88059-01
CP-88,059
CP-88,059-01
CP-88,059-1
CP-88059-1
CPD000466328
D08687
DB00246
Geodon
|
Geodon Oral
I14-0766
L000659
LS-83744
MLS000759435
MolPort-003-850-885
SAM001246607
SMR000466328
TL8000889
UNII-6UKA5VEJ6X
Zeldox
Zipradon
Zipradon (TN)
ziprasidona
Ziprasidona
Ziprasidone
Ziprasidone (INN)
Ziprasidone [INN:BAN]
Ziprasidone hydrochloride
Ziprasidone hydrochloride, monohydrate
Ziprasidone mesylate trihydrate
ziprasidonum
Ziprasidonum
ziprazidone
Ziprazidone
|
|
20 |
|
Magnesium oxide |
Approved |
Phase 4 |
|
1309-48-4 |
14792 |
Synonyms:
|
21 |
|
Atorvastatin |
Approved |
Phase 4 |
|
134523-00-5 |
60823 |
Synonyms:
(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid
(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
(betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
134523-00-5
134523-03-8
7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]- 3,5-DIHYDROXY-HEPTANOIC ACID
7-[2-(4-FLUORO-phenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoate
7-[2-(4-FLUORO-phenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoIC ACID
AC-15611
AC1L1TZT
AC1Q1OZQ
AKOS000281127
Anhydrous, atorvastatin calcium
Atogal
Atorlip
Atorpic
atorvastatin
Atorvastatin
Atorvastatin (INN)
Atorvastatin [INN:BAN]
Atorvastatin acid
Atorvastatin calcium
Atorvastatin calcium anhydrous
Atorvastatin calcium hydrate
Atorvastatin calcium trihydrate
Atorvastatin, calcium salt
atorvastatina
Atorvastatina
atorvastatine
Atorvastatine
atorvastatinium
atorvastatinum
Atorvastatinum
atrovastin
BIDD:GT0336
C06834
C33H35FN2O5
|
Calcium anhydrous, atorvastatin
Calcium hydrate, atorvastatin
Calcium salt atorvastatin
Calcium trihydrate, atorvastatin
Calcium, atorvastatin
Cardyl
CCRIS 7159
CHEBI:39548
CHEMBL1487
CI 981
CID60823
D07474
DB01076
Faboxim
Hipolixan
HSDB 7039
Hydrate, atorvastatin calcium
Lipitor
Lipitor (TN)
Lipitor(TM)
Lipotropic
Lipovastatinklonal
Liprimar
Liptonorm
Lowden
LS-136975
MolPort-000-883-773
NCGC00159458-02
nchembio.301-comp8
Normalip
Sincol
Sortis
Sortis (TN)
Sotis
Torvacard
Torvast
Totalip
Tozalip
Trihydrate, atorvastatin calcium
Tulip
UNII-A0JWA85V8F
Vastina
Xanator
Xarator
Xavator
Zurinel
|
|
22 |
|
Fenofibrate |
Approved |
Phase 4 |
|
49562-28-9 |
3339 |
Synonyms:
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoate 1-methylethyl ester
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester
49562-28-9
AB00052196
Abbott brand OF procetofen
Abbott Brand of Procetofen
AbZ brand OF procetofen
AbZ Brand of Procetofen
AC1L1FPK
AC-4227
AKOS005107777
Aliud brand OF procetofen
Aliud Brand of Procetofen
Ankebin
Antara
Antara (micronized)
Antara (TN)
Antara micronized procetofen
Antara Micronized Procetofen
Anto brand OF procetofen
Anto Brand of Procetofen
Apo feno micro
Apo Feno Micro
Apo fenofibrate
Apo Fenofibrate
Apo-fenofibrate
Apo-Fenofibrate
Apo-feno-micro
Apo-Feno-Micro
Apotex brand OF procetofen
Apotex Brand of Procetofen
AZU, fenofibrat
AZU, Fenofibrat
Azupharma brand OF procetofen
Azupharma Brand of Procetofen
betapharm Brand of Procetofen
Betapharm brand OF procetofen
BIDD:GT0574
Bouchara brand OF procetofen
Bouchara Brand of Procetofen
BPBio1_000166
BRD-K50388907-001-05-6
BRN 2062462
BSPBio_000150
BSPBio_003162
C07586
C20H21ClO4
CAS-49562-28-9
CCRIS 7282
CHEBI:5001
CHEMBL672
CID3339
CiL
CIP-Fenofibrate
Controlip
CPD000058299
ct Arzneimittel Brand of Procetofen
CT Arzneimittel brand OF procetofen
ct-Arzneimittel Brand of Procetofen
CT-Arzneimittel brand OF procetofen
D00565
D011345
DB01039
Debat, Fenofibrate
Debat, fénofibrate
DivK1c_000557
durafenat
Durafenat
EINECS 256-376-3
Elasterate
Elasterin
EU-0100486
F 6020
F6020_SIGMA
Fenobeta
Fenobrate
Fenofanton
Fenofibrat abz
Fenofibrat AbZ
Fenofibrat al
Fenofibrat AL
Fenofibrat azu
Fenofibrat AZU
Fenofibrat FPh
Fenofibrat FPH
Fenofibrat heumann
Fenofibrat Heumann
Fenofibrat hexal
Fenofibrat Hexal
Fenofibrat ratiopharm
Fenofibrat stada
Fenofibrat Stada
fenofibrat von ct
Fenofibrat von CT
fenofibrate
Fenofibrate
Fenofibrate (JAN/INN)
FENOFIBRATE (MICRONIZED)
Fenofibrate [INN:BAN]
Fenofibrate Debat
Fénofibrate debat
Fenofibrate IDD-P
Fenofibrate MSD
Fénofibrate MSD
Fenofibrato
Fenofibrato [INN-Spanish]
Fenofibrat-ratiopharm
Fenofibratum
Fenofibratum [INN-Latin]
fenofibric acid
Fenofibric acid
Fenogal
Fenoglide
Fenomax
Fenotard
Finofibrate
Finofibric acid
FNF
Fournier brand OF procetofen
Fournier Brand of Procetofen
Fulcro
gate Brand OF procetofen
Gate Brand of Procetofen
Gen fenofibrate
Gen Fenofibrate
Gen-fenofibrate
Gen-Fenofibrate
Genpharm brand OF procetofen
Genpharm Brand of Procetofen
GNR Pharma brand OF procetofen
GNR Pharma Brand of Procetofen
GNR-Pharma brand OF procetofen
GNR-Pharma Brand of Procetofen
GRS-027
Heumann brand OF procetofen
Heumann Brand of Procetofen
Heumann, fenofibrat
Heumann, Fenofibrat
Hexal brand OF procetofen
Hexal Brand of Procetofen
Hexal, fenofibrat
Hexal, Fenofibrat
HMS1568H12
HMS1921B17
HMS2090G20
HMS2092B05
HMS501L19
I06-0048
IDI1_000557
Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate
Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionic acid
Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate
|
Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionic acid
Isopropyl 2-(p-(p-chlorobenzoyl)phenoxy)-2-methylpropionate
isopropyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate
KBio1_000557
KBio2_001730
KBio2_004298
KBio2_006866
KBio3_002382
KBioGR_000706
KBioSS_001730
Knoll brand OF procetofen
Knoll Brand of Procetofen
LCP-Feno
LCP-FenoChol
LF 178
LF178
LF-178
Lichtenstein brand OF procetofen
Lichtenstein Brand of Procetofen
Lipanthyl
Lipantil
Lipantil (TN)
Liparison
Lipidex
Lipidil
Lipidil Micro
Lipidil Supra
Lipidil ter
Lipidil Ter
Lipidil-ter
Lipidil-Ter
Lipifen
Lipirex
Lipoclar
Lipofen
Lipofen (TN)
Lipofene
Liposit
Lipsin
Livesan
Lofibra
Lopac0_000486
Lopac-F-6020
LS-121256
Luxacor
Merck dura brand OF procetofen
Merck dura Brand of Procetofen
Micronized procetofen, antara
Micronized Procetofen, Antara
MLS000028515
MLS001148191
MolPort-002-887-051
MTW Brand of Procetofen
MTW Brand OF procetofen
MTW Fenofibrat
MTW-Fenofibrat
NCGC00015437-01
NCGC00015437-02
NCGC00015437-03
NCGC00015437-06
NCGC00015437-12
NCGC00021475-03
NCGC00021475-04
NCGC00021475-05
NCGC00021475-06
NCGC00021475-07
NCGC00021475-08
nchembio790-comp24
NINDS_000557
Nolipax
Normalip
Novartis brand OF procetofen
Novartis Brand of Procetofen
Novo fenofibrate
Novo Fenofibrate
Novo-fenofibrate
Novo-Fenofibrate
Novopharm brand OF procetofen
Novopharm Brand of Procetofen
NSC 281319
NSC281319
Nu fenofibrate
Nu Fenofibrate
Nu pharm brand OF procetofen
Nu Pharm Brand of Procetofen
Nu-fenofibrate
Nu-Fenofibrate
Nu-pharm brand OF procetofen
Nu-Pharm Brand of Procetofen
Pharmascience brand OF procetofen
Pharmascience Brand of Procetofen
Pharmavit
Phenofibrate
PMS Fenofibrate micro
PMS Fenofibrate Micro
PMS-Fenofibrate micro
PMS-Fenofibrate Micro
Prestwick_217
Prestwick0_000275
Prestwick1_000275
Prestwick2_000275
Prestwick3_000275
Procetofen
Procetofen reliant brand
Procetofen Reliant Brand
Procetofen, antara micronized
Procetofen, Antara Micronized
Procetofene
Proctofene
Protolipan
Q Pharm brand OF procetofen
Q Pharm Brand of Procetofen
Q-Pharm brand OF procetofen
Q-Pharm Brand of Procetofen
ratiopharm Brand of Procetofen
Ratiopharm brand OF procetofen
Reliant brand OF procetofen
Reliant Brand of Procetofen
S1794_Selleck
SAM002264613
Schering plough brand OF procetofen
Schering Plough Brand of Procetofen
Schering-plough brand OF procetofen
Schering-Plough Brand of Procetofen
Secalip
Sedufen
SMR000058299
SPBio_001380
SPBio_002369
Spectrum_001250
SPECTRUM1501010
Spectrum2_001390
Spectrum3_001431
Spectrum4_000413
Spectrum5_001479
ST085313
Stada, fenofibrat
Stada, Fenofibrat
Stadapharm brand OF procetofen
Stadapharm Brand of Procetofen
Supralip
TL8003296
Tricor
TRICOR (MICRONIZED)
Tricor (TN)
Triglide
Triglide (TN)
Trilipix
UNII-U202363UOS
United drug brand OF procetofen
United Drug Brand of Procetofen
ZINC00584092
|
|
23 |
|
Telmisartan |
Approved, Investigational |
Phase 4 |
|
144701-48-4 |
65999 |
Synonyms:
144701-48-4
2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylate
4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid
4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylate
4'-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylate
4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid
4'-[(1,7'-Dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylate
4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
4'-[(1,7'-Dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
Abbott brand of telmisartan
AC1L24EB
AC1Q5U7O
AC-2013
Bay 68-9291
BAY68-9291
BAY-68-9291
BIBR 277
BIBR 277Se
BIBR 277SE
BIBR-277
BIBR-277SE
BIBR-277-SE
BIDD:GT0365
Bio-0103
Boehringer Ingelheim brand of telmisartan
BRD-K73999723-001-02-2
BSPBio_002738
C07710
C084178
C33H30N4O2
CHEBI:9434
CHEMBL1017
CID65999
CPD000466326
D00627
DB00966
|
Glaxo Wellcome brand of telmisartan
GlaxoSmithKline brand of telmisartan
HMS1922P07
HMS2051P16
HMS2090P17
HMS2093M22
HSDB 7590
I06-0281
KBio3_001958
KBioGR_001842
Kinzal
Kinzalmono
L001035
LS-44263
Micardis
Micardis (TN)
Micardis HCT
Micardis, Targit, Temax, BIBR277, Telmisartan
MLS000759432
MLS001076687
MolPort-003-666-621
NCGC00095150-01
NCGC00095150-02
NCGC00095150-03
Pritor
S1738_Selleck
SAM001246602
SMR000466326
SPBio_002131
SPECTRUM1505261
Spectrum2_001976
Spectrum3_001089
Spectrum4_001261
Spectrum5_001053
STK624049
telmisartan
Telmisartan
Telmisartan (JAN/USAN/INN)
Telmisartan [USAN:INN]
Telmisartan tablets
TL8000991
UNII-U5SYW473RQ
YM-086
|
|
24 |
|
Levoleucovorin |
Approved, Investigational |
Phase 4 |
|
68538-85-2 |
149436 |
Synonyms:
(6S)-5-Formyl-5,6,7,8-tetrahydrofolate
(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid
(6S)-5-Formyltetrahydrofolate
(6S)-5-formyltetrahydrofolic acid
(6S)-5-Formyltetrahydrofolic acid
(6S)-Folinate
(6S)-Folinic acid
(6S)-Leucovorin
(S)-Leucovorin
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formyl-(6S)-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
6 S Leucovorin
6S Leucovorin
6S-Leucovorin
6-S-Leucovorin
Acid, folinic
ácido levofolínico
Calcium folinate
Calcium leucovorin
CF
Citrovorum factor
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid SF
Folinic acid-SF
Fusilev
Kunyrin
Leucoverin
|
Leucovorin
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, (S)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, (S)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monopotassium salt, (S)-isomer
Leucovorin, monosodium salt
Leucovorin, monosodium salt, (S)-isomer
Leukovorin
Leukovorum
Levo leucovorin
Levofolene
Levofolinate
Levofolinic acid
Levoleucovorin
Levo-leucovorin
L-Folinate
L-Folinic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamate
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolic acid
N5-Formyl-THF
Pteroyl-D-glutamate
S Leucovorin
S-Leucovorin
Welcovorin
Wellcovorin
|
|
25 |
|
Meropenem |
Approved, Investigational |
Phase 4 |
|
96036-03-2, 119478-56-7 |
64778 441130 |
Synonyms:
(1R,5S,6S)-2-[(3S,5S)-5-(dimethylaminocarbonyl)pyrrolidin-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid trihydrate
(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate
(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylIC ACID
(2S,3R,4R)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-{[(3S,5R)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid
(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5S,6S)-3-((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-ylthio)-6-((S)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(6S)-2-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-1beta-methyl-2,3-didehydro-1-carbapenam-3-carboxylic acid
3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
96036-03-2
AB00514051
AB1004614
AC1L9ALL
Ambap119478-56-7
Antibiotic SM 7338
BIDD:GT0851
BPBio1_001334
BSPBio_001212
CHEBI:43968
CHEMBL127
CID441130
CPD000469184
D08185
HMS1571M14
HMS2051G08
HMS2090C05
|
ICI-194660
MEPM
Meronem
MERONEM
Meronem (TN)
Meropen
Meropenem
Meropenem (INN)
Meropenem anhydrous
Meropenemum
Merrem
Merrem i.v.
Merrem I.V. (TN)
MLS001401437
MolPort-006-709-417
NCGC00179259-01
Penem
Prestwick0_001106
Prestwick1_001106
Prestwick2_001106
Prestwick3_001106
Ronem
SAM001246650
SM-7338
SMR000469184
SPBio_003086
|
|
26 |
|
Ertapenem |
Approved, Investigational |
Phase 4 |
|
153832-46-3 |
150610 |
Synonyms:
(1R,5S,6S,8R,2's,4's)-2-(2-(3-Carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylate
(1R,5S,6S,8R,2's,4's)-2-(2-(3-Carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid
(1R,5S,6S,8R,2'S,4'S)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid
(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate
(4R,5S,6S)-3-((3S,5S)-5-((3-carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4R,5S,6S)-3-({(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl}sulfanyl)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4R,5S,6S)-3-[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
153832-46-3
AC1L44OL
AC-6814
CHEBI:404903
CHEMBL1359
CID150610
|
D07908
DB00303
Ertapenem
Ertapenem (INN)
Ertapenem [INN]
Ertapenem sodium
I06-0484
Invanoz
Invanz
Invanz (TN)
LS-187017
LS-187767
MolPort-005-935-353
UNII-G32F6EID2H
|
|
27 |
|
Doxycycline |
Approved, Investigational, Vet_approved |
Phase 4 |
|
564-25-0 |
54671203 |
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
24390-14-5
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
41411-66-9 (6-epimer, mono-hydrochloride)
564-25-0
5-Hydroxy-a-6-deoxytetracycline
5-Hydroxy-alpha-6-deoxytetracycline
5-hydroxy-α-6-deoxytetracycline
5-Hydroxy-α-6-deoxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6a-Deoxy-5-oxytetracycline
6alpha-deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
6alpha-Deoxy-5-oxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-Deoxyoxytetracycline
6-Deoxytetracycline
6α-deoxy-5-oxytetracycline
6Α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
Alti-Doxycycline
Anhydrous doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
Deoxymykoin
DivK1c_000345
DMSC (*Fosfatex)
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
DOXCYCLINE ANHYDROUS
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
DOXY
Doxy-Caps
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
doxycycline
|
Doxycycline
Doxycycline (200mg/day) or Placebo
Doxycycline (anhydrous)
Doxycycline (INN)
Doxycycline (internal use)
Doxycycline (TN)
Doxycycline anhydrous
DOXYCYCLINE CALCIUM
Doxycycline hyclate
Doxycycline monohydrate
DOXYCYCLINE MONOHYDRATE
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxy-Puren
Doxysol
Doxy-Tabs
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
Liviatin
Lopac0_000405
LS-187766
LS-93868
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
Novo-Doxylin
NSC633557
Nu-Doxycycline
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
Spanor
SPBio_000246
SPBio_002784
Spectrum_000807
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
STOCK1N-34341
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Novum
Vibramycine
Vibra-tabs
Vibravenos
Vivox (*Hyclate)
|
|
28 |
|
Rosiglitazone |
Approved, Investigational |
Phase 4 |
|
122320-73-4 |
77999 |
Synonyms:
(±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione
(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion
[3H]rosiglitazone
122320-73-4
2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- (9CI)
5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-((4-(2-(Methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate
5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione
5-[[4-[2-(methyl-(2-pyridyl)amino)ethoxy]phenyl]methyl] thiazolidine-2,4-dione
5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
AC1L2U9N
AC-3459
Avandia
BRD-A97437073-001-02-3
BRD-A97437073-001-03-1
Brl 49653
Brl-49653
BRL49653
BRL-49653
BSPBio_002693
C18H19N3O3S
CID77999
D08491
DB00412
Gaudil
Gaudil (TN)
Glaxo wellcome brand OF rosiglitazone maleate
GlaxoSmithKline brand OF rosiglitazone maleate
HMS1922J11
HMS2094O13
HSDB 7555
I06-0141
IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin)
KBio2_002183
KBio2_004751
KBio2_007319
|
KBio3_001913
KBioGR_001609
KBioSS_002183
LS-151340
MolPort-002-508-212
NCGC00095124-01
NCGC00095124-02
NCGC00095124-03
RGZ
Rosi
Rosigilitazone
Rosigliazone maleate
Rosiglitazon
rosiglitazona
Rosiglitazona
rosiglitazone
Rosiglitazone
rosiglitazone (Avandia)
Rosiglitazone (INN)
Rosiglitazone [INN:BAN]
Rosiglitazone maleate
rosiglitazonum
Rosiglitazonum
Rosiglizole
RSG
S00306
SmithKline beecham brand OF rosiglitazone maleate
SPBio_001142
Spectrum_001703
SPECTRUM1504263
Spectrum2_001241
Spectrum3_000997
Spectrum4_001125
Spectrum5_001464
STOCK6S-23924
TDZ 01
UNII-05V02F2KDG
|
|
29 |
|
Calcium carbonate |
Approved, Investigational |
Phase 4 |
|
471-34-1 |
|
Synonyms:
Calcio carbonato
Calcium carbonate (1:1)
Calciumcarbonat
Carbonate de calcium
Carbonato de calcio
|
Carbonic acid calcium salt (1:1)
Chalk
Kalziumkarbonat
Kohlensaurer kalk
Precipitated calcium carbonate
|
|
30 |
|
Olmesartan |
Approved, Investigational |
Phase 4 |
|
144689-24-7, 144689-63-4 |
158781 130881 |
Synonyms:
144689-24-7
4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid
4-(Hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid
4-(Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid
AC1L4KLS
Benicar
Benicar HCT
C437965
CHEBI:48416
CHEMBL1516
CID158781
CPD000466337
CS-088
D05246
DE-092
|
HMS2051K12
I14-10085
L001097
LS-181800
MLS000759446
MLS001424016
MolPort-003-666-606
olmesartan
Olmesartan
Olmesartan (USAN/INN)
Olmesartan [USAN]
Olmesartan medoximil
Olmesartan medoxomil
Olmetec
omesartan
Omesartan
RNH 6270
RNH-6270
SAM001246634
SMR000466337
UNII-8W1IQP3U10
Votum
|
|
31 |
|
Octreotide |
Approved, Investigational |
Phase 4 |
|
83150-76-9 |
383414 6400441 |
Synonyms:
(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
(4R,7S,10S,13R,16S,19R)-19-{[(2R)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-6,9,12,15,18-pentahydroxy-7-(1-hydroxyethyl)-13-[(1H-indol-3-yl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carboximidate
10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaa
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
79517-01-4 (acetate salt)
83150-76-9
AC1L1GVU
AC1L8LCD
AC1L9M4X
C07306
C5H12O2.C4H10
CHEBI:427278
CHEBI:611465
CHEMBL1680
CID383414
CID448601
CID54374
Compound 201 995
Compound 201995
Compound 201-995
D00442
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide
DRG-0115
HMS2090C09
HS-2020
L000453
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R*
|
Longastatin
LS-177735
LS-187135
NCGC00181796-01
nchembio.184-comp3
NCI60_025753
Octreotida
Octreotida [Spanish]
Octreotide
Octreotide (USAN/INN)
Octreotide [USAN:INN:BAN]
Octreotide acetate
Octreotide acetate salt
Octreotide Acetate Salt
Octreotide-LAR
Octreotidum
Octreotidum [Latin]
Octrotide
SAN 201-995
Sandostatin
Sandostatine
Sandoz 201 995
Sandoz 201995
Sandoz 201-995
SM 201-995
SMS 201-995
SMS-201-995
UNII-RWM8CCW8GP
zacycloicosane-4-carboxamide acetate
|
|
32 |
|
Tadalafil |
Approved, Investigational |
Phase 4 |
|
171596-29-5 |
110635 |
Synonyms:
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
171596-29-5
1xoz
351, IC
6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
AC1L380B
Acdirca
Adcirca
ADCIRCA
C429886
CHEBI:41488
CHEMBL779
Cialis
Cialis (TN)
Cialis, GF 196960, IC 351, ICOS 351, Tadalafil
CID110635
CPD000466321
D02008
DB00820
FT-0080116
GF 196960
GF-196960
HMS2051N17
|
HSDB 7303
IC 351
Ic351
IC-351
ICOS 351
KS-1117
Lilly brand of tadalafil
LS-186558
LS-187015
LS-187770
MLS000759426
MLS001165782
MLS001195644
MLS001424132
MolPort-002-885-864
S1512_Selleck
SAM001246586
SMR000466321
Tadalafil
Tadalafil (JAN/USAN/INN)
Tadalafil [USAN]
Tadalafilo
Tadanafil
UNII-742SXX0ICT
Zalutia
ZINC03993855
|
|
33 |
|
Repaglinide |
Approved, Investigational |
Phase 4 |
|
135062-02-1 |
65981 |
Synonyms:
(+)-2-Ethoxy-alpha-(((S)-alpha-isobutyl-o-piperidinobenzyl)carbamoyl)-p-toluic acid
(S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
(S)-2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)-phenyl)butyl)amino)-2-oxoethyl)-benzoic acid
(S)-2-Ethoxy-4-(2-((methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-benzoic acid
111GE012
135062-02-1
2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid
2-Ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid
2-ethoxy-4-(2-{[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino}-2-oxoethyl)benzoic acid
2-ethoxy-4-[2-({(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid
2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid
2-ethoxy-N-(alpha-(2-methyl-1-propyl)-2-piperidinobenzyl)-4-carbamoylmethylbenzoic acid
2-Ethoxy-N-(alpha-(2-methyl-1-propyl)-2-piperidinobenzyl)-4-carbamoylmethylbenzoic acid
AB00514019
AC1L24D5
AC1Q5TZW
AC-726
Actulin
AG-ee 388
AG-EE 388
AG-ee 388 ZW
AG-EE 388 ZW
AG-ee 623 ZW
AG-EE 623 ZW
AG-EE-388
AG-EE-623 ZW
AGEE-623ZW
BIDD:GT0338
Bio-0087
BPBio1_001070
BRD-K82846253-001-03-0
BSPBio_000972
C072379
C07670
C27H36N2O4
CAS-135062-02-1
CHEBI:348669
CHEMBL1272
CID65981
CPD000466305
D00594
DB00912
Glaxo wellcome brand OF replaginide
Glaxo Wellcome brand of replaginide
|
GlucoNorm
HMS1571A14
HMS2051N08
HMS2094C07
LS-38509
MLS000759407
MLS001076684
MolPort-003-850-140
NCGC00016978-01
NCGC00016978-02
NN-623
Novo nordisk brand 2 OF repaglinide
Novo Nordisk brand 2 of repaglinide
Novo nordisk brand OF repaglinide
Novo Nordisk brand of repaglinide
NovoNorm
Prandin
Prandin (TN)
Prandin, GlucoNorm, NovoNorm, Repaglinide
Prestwick0_001046
Prestwick1_001046
Prestwick2_001046
Prestwick3_001046
R9028_SIGMA
Repaglinida
Repaglinida [INN-Spanish]
repaglinide
repa-glinide
Repaglinide
Repa-glinide
Repaglinide (JAN/USP/INN)
Repaglinide [USAN]
repaglinide, (+-)-isomer
Repaglinide, (+-)-isomer
Repaglinidum
Repaglinidum [INN-Latin]
S1426_Selleck
SAM001246546
SMP-508
SMR000466305
SPBio_002906
STK629501
Surepost
UNII-668Z8C33LU
|
|
34 |
|
Losartan |
Approved |
Phase 4 |
|
114798-26-4 |
3961 |
Synonyms:
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
114798-26-4
124750-99-8 (mono-potassium salt)
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol
2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol
2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole
AC1L1H3Q
BIDD:GT0286
BRD-K76205745-001-02-5
BSPBio_002695
C07072
C22H23ClN6O
CHEBI:6541
CHEMBL191
CID3961
CL23623
Cozaar
D08146
DB00678
DuP 753
DUP 89
DuP-753
HMS1922J13
HMS2093E22
Hyzaar
I14-9710
Jsp001094
KBio2_002193
KBio2_004761
|
KBio2_007329
KBio3_001915
KBioGR_001611
KBioSS_002193
L000351
Lortaan
losartan
Losartan
Losartan (INN)
Losartan [INN:BAN]
Losartan monopotassium salt
losartan potassium
Losartan potassium
LOSARTAN POTASSIUM
Losartic
Losartic (TN)
LS-78746
MK954
MK-954
MolPort-003-666-553
Monopotassium salt, losartan
NCGC00095125-01
NCGC00095125-02
NCGC00095125-03
Oprea1_644635
Potassium, losartan
Salt, losartan monopotassium
SPBio_001893
Spectrum_001713
SPECTRUM1504268
Spectrum2_001677
Spectrum3_000998
Spectrum4_001126
Spectrum5_001466
UNII-JMS50MPO89
|
|
35 |
|
Coal tar |
Approved |
Phase 4 |
|
8007-45-2 |
|
Synonyms:
|
36 |
|
Ofloxacin |
Approved |
Phase 4 |
|
82419-36-1 |
4583 |
Synonyms:
( -)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure
(+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperaz inyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7- -oxo-7H-pyrido(1,2,3-de)- -1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(+/-)-Floxin
118120-51-7 (hydrochloride)
33703_FLUKA
33703_RIEDEL
82419-36-1
83380-47-6
85344-55-4
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylate
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
AB00513820
AC1L1IHM
AC-7616
Akilen
AKOS001033517
Baccidal
Bactocin
BB_SC-1252
BPBio1_000345
BRD-A24228527-001-05-9
BRN 3657947
BSPBio_000313
BSPBio_003117
C07321
C18H20FN3O4
CCRIS 5233
CHEBI:7731
CHEMBL4
CID4583
CPD000058192
D00453
Danoflox
DB01165
DEXTROFLOXACINE
DivK1c_000721
DL 8280
DL-8280
DL-8280, HOE-280, Exocin, Flobacin, Floxin, Floxil, Monoflocet, Ofloxacin
Effexin
EU-0100904
Exocin
Exocine
Flobacin
Flodemex
Flotavid
Flovid
Floxal
Floxil
Floxin
Floxin (TN)
FLOXIN IN DEXTROSE 5%
FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Floxin otic
Floxstat
Fugacin
HMS1568P15
HMS1921H12
HMS2090F07
HMS2092B10
HMS502E03
Hoe 280
HOE 280
Hoe-280
I06-0112
I06-0380
IDI1_000721
Inoflox
KBio1_000721
KBio2_001666
KBio2_004234
KBio2_006802
KBio3_002617
KBioGR_000667
KBioSS_001666
Kinflocin
Kinoxacin
Liflox
Lopac0_000904
Loxinter
LS-133259
Marfloxacin
Medofloxine
Mergexin
MLS000028749
MLS001074203
MolPort-000-422-241
MolPort-000-873-068
NCGC00015772-02
NCGC00015772-10
|
NCGC00094219-01
NCGC00094219-02
NCGC00094219-03
NCGC00094219-04
NCGC00094219-05
NCGC00094219-06
NCGC00178284-01
NCGC00178284-02
NINDS_000721
Novecin
NSC727071
Nufafloqo
O 8757
O8757_SIGMA
Obide
Occidal
Ocuflox
Ofcin
Oflin
Oflocee
Oflocet
Oflocin
Oflodal
Oflodex
Oflodura
Oflox
O-Flox
ofloxacin
Ofloxacin
Ofloxacin (JP15/USP/INN)
Ofloxacin [USAN:BAN:INN:JAN]
Ofloxacin hydrochloride
Ofloxacin Otic
Ofloxacin, (S)-Isomer
Ofloxacina
Ofloxacina [DCIT]
Ofloxacine
Ofloxacine [French]
Ofloxacino
Ofloxacino [Spanish]
Ofloxacinum
Ofloxacinum [Latin]
Ofloxin
OFLX
Ofus
OFX
Onexacin
Operan
Oprea1_242882
ORF 18489
ORF-28489
Orocin
Otonil
Oxaldin
Pharflox
Praxin
Prestwick0_000237
Prestwick1_000237
Prestwick2_000237
Prestwick3_000237
PT 01
Puiritol
Qinolon
Qipro
Quinolon
Quotavil
Rilox
Ru-43280
S1463_Selleck
SAM002264629
Sinflo
SMR000058192
SPBio_001387
SPBio_002234
Spectrum_001186
SPECTRUM1502044
Spectrum2_001464
Spectrum3_001499
Spectrum4_000324
Spectrum5_001063
STK256723
Tabrin
Taravid
Tariflox
Tarivid
Telbit
Tructum
UNII-A4P49JAZ9H
Uro Tarivid
Viotisone
Visiren
WP-0405
XED
Zanocin
|
|
37 |
|
Levofloxacin |
Approved, Investigational |
Phase 4 |
|
100986-85-4 |
149096 |
Synonyms:
(−
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-Ofloxacin
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate
(3S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(R)-isomer
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylate
(S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-(-)-Ofloxacin
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylate
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-Ofloxacin
)-Ofloxacin
100986-85-4
100986-86-5
28266_FLUKA
28266_SIGMA
AC1L3YF8
AC-7593
Aeroquin
Ambap100986-85-4
Anhydrous, levofloxacin
BRD-K09471561-001-06-7
BSPBio_002689
C07660
C18H20FN3O4
C18H20FN3O4.H2O
CCRIS 4073
CCRIS 4074
CHEMBL33
CID149096
CPD000466387
Cravit
Cravit (TN)
Cravit Ophthalmic
D08120
DB01137
d-Levofloxacin
DR 3354
DR3355
DR-3355
DR-3355: L-isomer of ofloxacin
Elequine
Floxacin
Floxel
Floxin
HMS1922J07
HMS2051G04
HMS2090O10
HMS2093E18
HR 355
HR-355
Iquix
KBio2_002199
KBio2_004767
|
KBio2_007335
KBio3_001909
KBioGR_001605
KBioSS_002199
L0193
Leroxacin
Lesacin
Levaquin
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Levofloxacin
LEVOFLOXACIN
Levofloxacin (INN)
Levofloxacin [USAN:INN:JAN]
Levofloxacin anhydrous
Levofloxacin hydrate
Levofloxacin tablet, suspension or intravenous
Levofloxacine
Levofloxacine [INN-French]
Levofloxacino
Levofloxacino [INN-Spanish]
Levofloxacinum
Levofloxacinum [INN-Latin]
Levokacin
Levox
Levoxacin
LFX
L-Ofloxacin
LS-133260
LS-171761
LVX
MLS000759524
MLS001165709
MLS001423977
MolPort-002-885-835
Mosardal
MP-376
NCGC00178529-01
Nofaxin
Ofloxacin
Ofloxacin S-(-)-form
Ofloxacin, (S)-isomer
Oftaquix
Quixin
Reskuin
R-Ofloxacin
RWJ 25213-097
RWJ-25213
S-(-)-Ofloxacin
S1940_Selleck
SAM001246758
SMR000466387
SPBio_001891
Spectrum_001719
SPECTRUM1504260
Spectrum2_001676
Spectrum3_000995
Spectrum4_001123
Spectrum5_001438
Tavanic
Volequin
|
|
38 |
|
Bazedoxifene |
Approved, Investigational |
Phase 4 |
|
198481-32-2 |
|
Synonyms:
|
39 |
|
Micafungin |
Approved, Investigational |
Phase 4 |
|
235114-32-6 |
3081921 477468 |
Synonyms:
5.1:6-anhydro{(4R,5R)-4,5-dihydroxy-N(2)-(4-{5-[4-(pentyloxy)phenyl]isoxazol-3-yl}benzoyl)-L-ornithyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-(3S,4S)-3-hydroxy-4-methyl-L-proline}
5-[(1S,2S)-2-{(2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-20-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-2,11,12,15-tetrahydroxy-6-[(1R)-1-hydroxyethyl]-16-methyl-5,8,14,19,22,25-hexaoxo-9-[(4-{5-[4-(pentyloxy)phenyl]isoxazol-3-yl}benzoyl)amino]tetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-23-yl}-1,2-dihydroxyethyl]-2-hydroxyphenyl hydrogen sulfate
AC1L9WY8
AC1MIXSV
AC-6107
CHEBI:600520
CHEMBL1201351
CID11804463
CID3081921
CID477468
CID6602291
DB01141
|
FK463
FK-463
I14-11710
LS-184079
LS-187369
Micafungin
Micafungin sodium
Micafungina
Mycamine
Mycamine(TM)
UNII-R10H71BSWG
|
|
40 |
|
Tedizolid |
Approved, Investigational |
Phase 4 |
|
856866-72-3 |
|
Synonyms:
|
41 |
|
Tedizolid phosphate |
Approved |
Phase 4 |
|
856867-55-5 |
|
Synonyms:
[(5R)-3-{3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl]phenyl}-2-oxo-1,3-oxazolidin-5-yl]methyl dihydrogen phosphate
Tedizolid phosphate
|
|
|
42 |
|
Posaconazole |
Approved, Investigational, Vet_approved |
Phase 4 |
|
171228-49-2 |
147912 |
Synonyms:
1-((1S,2S)-1-Ethyl-2-hydroxypropyl)-4-{4-[4-(4-{[(5S,3R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazolylmethyl)oxolan-3-yl]methoxy}phenyl)piperazinyl]phenyl}-1,2,4-triazolin-5-one
171228-49-2
177571-33-4
4-(p-(4-(p-(((3R,5R)-5-(2,4-Difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)-3-furyl)methoxy)phenyl)-1-piperazinyl)phenyl)-1-((1S,2S)-1-ethyl-2-hydroxypropyl)-delta(sup 2)-1,2,4-triazolin-5-one
4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one
4-[4-[4-[4-[[(5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one
AC-1350
AC1L3W34
AC1LAHLQ
AKOS005145917
CHEBI:434337
CHEMBL1397
CHEMBL371938
CHEMBL371939
CID10532764
CID11520437
CID11542142
CID147912
CID468595
D02555
DB01263
|
HSDB 7421
LS-186118
LS-186988
LS-187630
MolPort-006-666-426
Noxafil
Noxafil (TN)
Noxafil, Posaconazole
posaconazole
Posaconazole
Posaconazole (USAN/INN)
Posaconazole [USAN:INN:BAN]
Posaconazole in combination with MGCD290
Posaconazole SP
S1257_Selleck
Sch 56592
SCH56592
SCH-56592
Spriafil
UNII-6TK1G07BHZ
X2N
|
|
43 |
|
Cyclophosphamide |
Approved, Investigational |
Phase 4 |
|
50-18-0, 6055-19-2 |
2907 |
Synonyms:
(-)-Cyclophosphamide
(+-)-Cyclophosphamide
(+,-)-2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide monohydrate
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
Anhydrous cyclophosphamide
Anhydrous, cyclophosphamide
ASTA
Asta B 518
ASTA B518
B 518
B-518
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
BRN 0011744
BSPBio_002099
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
CID2907
Clafen
Claphene
CP
CPA
CTX
CY
Cycloblastin
Cyclophosphamid
cyclophosphamide
Cyclophosphamide
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide anhydrous
Cyclophosphamide monohydrate
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide, (+-)-Isomer
Cyclophosphamide, (R)-isomer
Cyclophosphamide, (S)-isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
|
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
DivK1c_000246
EINECS 200-015-4
Endoxan
Endoxan R
Endoxana
Endoxanal
Endoxan-Asta
Endoxane
Enduxan
EU-0100238
Genoxal
Hexadrin
HMS2090A12
HSDB 3047
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
Lopac0_000238
Lopac-C-0768
LS-1302
LS-99787
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
Monohydrate, cyclophosphamide
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI60_002097
NCI-C04900
Neosar
NINDS_000246
NSC 26271
NSC26271
NSC-26271
NSC273033
NSC273034
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra waste number U058
Rcra Waste Number U058
Revimmune
S1217_Selleck
Semdoxan
Sendoxan
Senduxan
SK 20501
SPBio_001071
Spectrum_000858
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
STK177249
STOCK2S-91217
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
|
|
44 |
|
Tacrolimus |
Approved, Investigational |
Phase 4 |
|
104987-11-3 |
445643 439492 6473866 |
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
Advagraf
AKOS005145901
Ambap104987-11-3
Ambap5429
Anhydrous tacrolimus
Anhydrous, tacrolimus
BCBcMAP01_000194
Bio-0921
Bio2_000470
Bio2_000950
BRD-K35452788-001-02-1
BSPBio_001279
BSPBio-001279
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
Cilag brand OF tacrolimus
CPD000466356
CPD-10016
D08556
DB00864
DivK1c_001040
FK 506
FK5
Fk-506
FK506
FK-506
FR 900506
FR900506
|
FR-900506
FT-0082660
Fujimycin
Fujisawa brand OF tacrolimus
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
IDI1_001040
IDI1_002225
Janssen brand OF tacrolimus
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
nchembio.2007.23-comp2
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Prograft
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
tacrolimus
Tacrolimus
Tacrolimus (anhydrous)
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus anhydrous
tacrolimus hydrate
Tacrolimus, anhydrous
Tsukubaenolide
UNII-Y5L2157C4J
|
|
45 |
|
Efavirenz |
Approved, Investigational |
Phase 4 |
|
154598-52-4 |
64139 |
Synonyms:
(-)-6-CHLORO-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(-)-Efavirenz
(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
(4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben
(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[D][1,3]oxazin-2-one
154598-52-4
1ikv
1ikw
2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)- (9
6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
6-Chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[D][1,3]oxazin-2-one
AC-19049
AC1L20IX
BIDD:GT0383
Bristol-myers squibb brand OF efavirenz
C08088
C14H9ClF3NO2
CHEBI:119486
CHEMBL223228
CID64139
CPD000466351
D00896
DB00625
DB07709
DMP 266
DMP-266
Du pont brand OF efavirenz
efavirenz
Efavirenz
|
Éfavirenz
Efavirenz (JAN/INN)
Efavirenz, (R)-isomer
efavirenz, (S)-isomer
Efavirenz, (S)-isomer
Efavirenzum
EFV
EFZ
Eravirenz
HMS2051J08
HMS2090N16
HSDB 7163
L 743726
L-741211
L-743,726
L-743725
L-743726
LS-173464
Merck sharp and dohme brand OF efavirenz
Met-SDF-1.beta. & Efavirenz
Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz
MLS000759465
MLS001424087
MolPort-003-983-924
NSC742403
SAM001246667
SBB066062
SMR000466351
Stocrin
Strocin (TM)
Sustiva
Sustiva (TM)
Sustiva (TN)
UNII-JE6H2O27P8
United drug brand OF efavirenz
ZINC02020233
zoxazin-2-one
|
|
46 |
|
Doxorubicin |
Approved, Investigational |
Phase 4 |
|
23214-92-8 |
31703 |
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside
(8S-cis)-10-((3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
(8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
(8S-cis)-10-((3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
(8S-cis)-10-((3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-hydroxydaunomycin
14-Hydroxydaunomycin
14-hydroxydaunorubicine
14-Hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
adiblastine (hydrochloride salt)
ADM
ADR
adr iablatina (hydrochloride salt)
Adriablastin
Adriablastine
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin semiquinone
Adriamycin Semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (hydrochloride salt)
Adriblastina (TN)
Adriblastine
adriblatina (hydrochloride salt)
Adrimedac
Aerosolized Doxorubicin
Baxter brand OF doxorubicin hydrochloride
Bedford brand OF doxorubicin hydrochloride
BPBio1_000502
BRD-K92093830-003-04-3
Bristol-myers squibb brand OF doxorubicin hydrochloride
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
Caelyx
CCRIS 739
Cell pharm brand OF doxorubicin hydrochloride
CHEBI:28748
CHEMBL179
CID31703
Columbia brand OF doxorubicin hydrochloride
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
Doxil
Doxo
Doxo cell
Doxo-cell
Doxolem
doxorubicin
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
|
Doxorubicin HCl
Doxorubicin hexal
Doxorubicin hydrochloride
Doxorubicin Hydrochloride
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin NC
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicina ferrer farm
Doxorubicina funk
Doxorubicina tedec
Doxorubicine
Doxorubicine [INN-French]
Doxorubicine baxter
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicinum
Doxorubicinum [INN-Latin]
Doxotec
DOX-SL
EINECS 245-495-6
Elan brand OF doxorubicin hydrochloride
Farmablastina (hydrochloride salt)
Farmiblastina
Ferrer brand OF doxorubicin hydrochloride
FI 106
Hexal brand OF doxorubicin hydrochloride
HMS2089H06
HSDB 3070
Hydrochloride, doxorubicin
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
Kenfarma brand OF doxorubicin hydrochloride
Lemery brand OF doxorubicin hydrochloride
LMPK13050001
LS-1029
LS-165655
Medac brand OF doxorubicin hydrochloride
MLS000759533
Myocet
NChemBio.2007.10-comp13
nchembio809-comp5
NCI-C01514
NDC 38242-874
Neocorp brand OF doxorubicin hydrochloride
NIOSH/JT9100000
NSC 123127
Onkodox
Onkoworks brand OF doxorubicin hydrochloride
Pfizer brand OF doxorubicin hydrochloride
Prasfarma brand OF doxorubicin hydrochloride
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Ribodoxo
Ribosepharm brand OF doxorubicin hydrochloride
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
Tedec meiji brand OF doxorubicin hydrochloride
ThermoDox
TLC D-99
Triferric doxorubicin
UNII-80168379AG
Urokit doxo cell
Urokit doxo-cell
|
|
47 |
|
Lactitol |
Approved, Investigational |
Phase 4 |
|
585-86-4 |
157355 |
Synonyms:
4-O-beta-D-Galactopyranosyl-D-glucitol
4-O-Î’-D-galactopyranosyl-D-glucitol
D-Lactitol
Emportal
Importal
|
Lactitol
Lactitolum
Neda lactiv importal
Oponaf
|
|
48 |
|
Valsartan |
Approved, Investigational |
Phase 4 |
|
137862-53-4 |
60846 |
Synonyms:
(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid
(S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
|Tareg
137862-53-4
AC1L1U1M
AC1Q5QIK
AC-4543
Ambap137862-53-4
Aventis brand of valsartan
BIDD:GT0345
Bio-0796
BRD-K45158365-001-02-3
BSPBio_003501
C081489
C24H29N5O3
CEPA brand of valsartan
CGP 48933
CGP-48933
CHEBI:9927
CHEMBL1069
CID60846
CPD000466318
D00400
DB00177
Diovan
Diovan (TN)
Diovan, Valsartan
Esteve brand of valsartan
HMS1922L21
HMS2051L12
HMS2093K22
HSDB 7519
Kalpress
KBio2_002287
KBio2_004855
KBio2_007423
KBio3_003006
KBioGR_001078
KBioSS_002289
Lacer brand of valsartan
|
LS-161334
L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
Miten
MLS000759423
MLS001424088
MolPort-002-507-854
MolPort-003-666-608
N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine
N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
N-(p-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
Nisis
Nisis||
Novartis brand of valsartan
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
N-Valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
Provas
S1894_Selleck
SAM001246581
Sanol brand of valsartan
Schwarz brand of valsartan
SMR000466318
SPBio_001260
Spectrum_001796
SPECTRUM1505209
Spectrum2_001120
Spectrum3_001831
Spectrum4_000749
Spectrum5_001582
Tareg
TL8000869
UNII-80M03YXJ7I
Vals
Valsarran
valsartan
Valsartan
Valsartan (JAN/USAN/INN)
Valsartan [USAN:INN]
walsartan
|
|
49 |
|
Parathyroid hormone |
Approved, Investigational |
Phase 4 |
|
9002-64-6 |
|
Synonyms:
Parathormone
Parathormone (human recombinant)
Parathyrin
Parathyroid hormone
Parathyroid hormone (1-84) human recombinant
Parathyroid hormone (rDNA)
|
PTH
PTH(1-84)
rhPTH
rhPTH(1-84)
rPTH
rPTH(1-84)
|
|
50 |
|
Memantine |
Approved, Investigational |
Phase 4 |
|
19982-08-2 |
4054 |
Synonyms:
1,3-Dimethyl-5-adamantanamine
1,3-Dimethyl-5-aminoadamantane
19982-08-2
1-Amino-3,5-dimethyladamantane
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-adamantylamine
3,5-Dimethyl-1-aminoadamantane
3,5-dimethyladamantan-1-amine
3,5-Dimethyladamantan-1-ylamine
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
3,5-dimethyltricyclo[3.3.1.1~3,7~]decan-1-amine
41100-52-1 (Hydrochloride)
51052-62-1
AB00053600
AC1L1HB7
AKOS000113995
Axura
BBL000737
Biomol-NT_000209
BPBio1_001117
BPBio1_001270
BSPBio_001015
C13736
CBMicro_020348
CHEBI:152523
CHEMBL807
CID4054
D08174
DB01043
DivK1c_000068
DMAA
Ebixa
EU-0053634
Exiba
Exiba (TN)
HMS500D10
HSDB 7327
IDI1_000068
KBio1_000068
KBio2_001087
KBio2_003655
KBio2_006223
|
KBio3_001926
KBioGR_001543
KBioSS_001087
Lopac0_000861
LS-157051
Lundbeck brand OF memantine hydrochloride
Memantin
Memantina
Memantina [INN-Spanish]
memantine
Memantine
Memantine (INN)
Memantine [INN:BAN]
Memantine [INN]
Memantine HCL
Memantine hydrochloride
Memantine Hydrochloride
Memantinum
Memantinum [INN-Latin]
Merz brand OF memantine hydrochloride
MolPort-002-041-858
Namenda
NCGC00015705-05
NCGC00024782-02
NCGC00024782-03
NINDS_000068
Oprea1_480562
Prestwick0_000978
Prestwick1_000978
Prestwick2_000978
Prestwick3_000978
SPBio_001456
SPBio_002926
Spectrum_000607
Spectrum2_001408
Spectrum3_000923
Spectrum4_001022
Spectrum5_001355
ST057652
STK520682
UNII-W8O17SJF3T
ZERO/006024
|
|
Interventional clinical trials:
(show top 50)
(show all 7730)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Vitamin D Concentrations and Their Effect on Glucose Metabolism in Pediatrics |
Unknown status |
NCT01386736 |
Phase 4 |
Vitamin D drops;Placebo drops |
2 |
Comparing the Efficacy of Two Frequently Used Doses of Enoxaparin for VTE Prophylaxis After Bariatric Surgery |
Unknown status |
NCT01970202 |
Phase 4 |
40mg Enoxaparin;60mg Enoxaparin |
3 |
The Effect of Obesity in Dexmedetomidine Metabolic Clearance |
Unknown status |
NCT02557867 |
Phase 4 |
Dexmedetomidine |
4 |
The Effect of Vitamin A Supplementation on CD4+ T-cell Secretion in Obese Individuals |
Unknown status |
NCT01405352 |
Phase 4 |
|
5 |
Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis: a Randomized, Investigator-blinded Study |
Unknown status |
NCT01439425 |
Phase 4 |
|
6 |
International, Multi Centre, Open, Prospective, Randomized Study: Banded Versus Conventional Laparoscopic Roux-en-Y (GABY) |
Unknown status |
NCT01015469 |
Phase 4 |
|
7 |
Study of the Concentrations of Long Acting Morphine After Oral Absorption in Subjects Who Underwent Gastric Bypass (OBEMO 2) |
Unknown status |
NCT02641301 |
Phase 4 |
Sustained release morphine sulfate, 30 mg |
8 |
Levonorgestrel-releasing Intrauterine Device Effects on Hemostatic and Arterial Function of Obese Women |
Unknown status |
NCT01320917 |
Phase 4 |
|
9 |
THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY |
Unknown status |
NCT03757650 |
Phase 4 |
Bismuth Subsalicylate |
10 |
Double-blind Randomized Trial Using Oral Metformin Versus Placebo in the Treatment of Acanthosis Nigricans in Children With Obesity |
Unknown status |
NCT02438020 |
Phase 4 |
Metformin |
11 |
Evaluation of the Effects of Laying Early (Between 12 and 16) a Gastric Band on the Prevention of Morbid Obesity in Late Adolescence. Randomized Checked Against Standard Management of Obesity in This Population. |
Unknown status |
NCT01700738 |
Phase 4 |
|
12 |
PRotective Effect on the Coronary Microcirculation of Patients With DIabetes by Clopidogrel or Ticagrelor |
Unknown status |
NCT02698618 |
Phase 4 |
Randomization |
13 |
Early Detection of Atherosclerosis in the Primary Care Setting: a Randomized Trial to Assess the Efficacy of a Novel Strategy in the Primary Prevention of Cardiovascular Diseases. |
Unknown status |
NCT00734123 |
Phase 4 |
Simvastatin or Atorvastatin;Enalapril;Aspirin or clopidogrel;Rimonabant |
14 |
Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients |
Unknown status |
NCT02933788 |
Phase 4 |
Cilostazol;Acetylsalicylic acid |
15 |
The Effect of Moxonidine and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension: a Randomised, Double Blind, Active Comparator Clinical Trial |
Unknown status |
NCT01360710 |
Phase 4 |
Moxonidine;Irbesartan |
16 |
Prevention and Control of Obesity in Primary School Children in Tehran |
Unknown status |
NCT02082080 |
Phase 4 |
|
17 |
A Study of the Pharmacokinetics of Dexmedetomidine in Morbid Obesity. |
Unknown status |
NCT01864187 |
Phase 4 |
Dexmedetomidine |
18 |
Comparing Dexlansoprazole With Double-dose Lansoprazole to Achieve Sustained Symptomatic Response in Overweight and Obesity Patients With Reflux Esophagitis in Los Angeles Grades A & B |
Unknown status |
NCT02759393 |
Phase 4 |
Dexlansoprazole;Lansoprazole |
19 |
Assessment of the Effect of Moxonidine and Diet on Cardiac, Renal and Endothelial Function in Young Subjects With Abdominal Obesity |
Unknown status |
NCT01180231 |
Phase 4 |
Moxonidine (Physiotens) |
20 |
Double Blinded Randomised Trial Comparing Metformin Versus Placebo in NASH Patients Receiving Bariatric Surgery for Obesity |
Unknown status |
NCT00134303 |
Phase 4 |
Metformin |
21 |
Effect of Saxagliptin on Body Fat , Glucose and Beta Cell Function in Patients With Newly Diagnosed Pre-Diabetes Mellitus and Obesity |
Unknown status |
NCT01960205 |
Phase 4 |
Saxagliptin;saxagliptin;metformin |
22 |
The Therapeutic Effect of Catgut Embedding in Obesity-A Randomized, Double-blind, Placebo-controlled Clinical Trial |
Unknown status |
NCT02276235 |
Phase 4 |
|
23 |
Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Overweight and Obesity Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Randomized Control Study |
Unknown status |
NCT02999841 |
Phase 4 |
Acarbose;Vildagliptin |
24 |
Healthy Opportunities for Physical Activity and Nutrition (HOP'N) After-School Project |
Unknown status |
NCT01015599 |
Phase 4 |
|
25 |
Laparoscopic Non Banded Vertical (Magenstrasse and Mill) Gastroplasty In Bariatric Surgery. Morbidity and Results on Weight Loss and Associated Co-morbidities |
Unknown status |
NCT02050477 |
Phase 4 |
|
26 |
Laparoscopic Roux-en-Y Gastric Bypass vs. Laparoscopic BPD-Duodenal Switch for Superobesity (BMI > 50 kg/m2)- A Randomized Clinical Trial |
Unknown status |
NCT00327912 |
Phase 4 |
|
27 |
Endobarrier Treatment in Obese Subjects With T2DM |
Unknown status |
NCT01718457 |
Phase 4 |
|
28 |
Correlation of Postoperative VAS Values and Body Mass Index in Patients Undergoing Abdominal Surgery: A Clinical Trial |
Unknown status |
NCT02017314 |
Phase 4 |
Morphine |
29 |
Laparoscopic Bariatric Surgery: Impact of the Level of Neuromuscular Blockade on Surgical Conditions - Comparison Between Moderate and Deep Neuromuscular Blockade |
Unknown status |
NCT02118844 |
Phase 4 |
rocuronium |
30 |
Prospective Randomized Study of Effects of Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy |
Unknown status |
NCT00667706 |
Phase 4 |
|
31 |
Prospective, Pharmacokinetic Study for Determination of the Relationship Between Lean Body Weight and Anti-Xa Activity 4 Hours After Subcutaneous Injection of 5700 IU Nadroparin in Morbidly Obese Patients After Bariatric Surgery. |
Unknown status |
NCT02295150 |
Phase 4 |
Nadroparin |
32 |
Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass |
Unknown status |
NCT02374632 |
Phase 4 |
|
33 |
Influence of the Aromatase Inhibitor Letrozole on Heart and Liver Function in Obese Men |
Unknown status |
NCT02097680 |
Phase 4 |
Letrozole;Placebo |
34 |
HYpertension Therapy With Valsartan Versus EpleRenone for Obese Patients: A Randomized Clinical Trial |
Unknown status |
NCT03476616 |
Phase 4 |
Eplerenone (-based therapy) arm;Valsartan (-based therapy) arm |
35 |
Evaluation of Family Intervention Program for the Treatment of Overweight or Obese Children (Nereu Program): Randomized Clinical Trial |
Unknown status |
NCT01878994 |
Phase 4 |
|
36 |
Study of Metabolic Effects of EndoBarrier Versus Intragastric Balloon in Obese Patients With Type 2 Diabetes. |
Unknown status |
NCT01848795 |
Phase 4 |
|
37 |
The Need of Dosing Adjustment for Simvastatin in Obese Patients Post Bariatric Surgery- Laparoscopic Sleeve Gastrectomy (LSG) |
Unknown status |
NCT03571802 |
Phase 4 |
Simvastatin |
38 |
Heparin Management for Cardiopulmonary Bypass in Cardiac Surgery: A Prospective, Comparative and Randomized Study Evaluating a Dosage Based on the Ideal Body Weight in Obese Patients |
Unknown status |
NCT02675647 |
Phase 4 |
Heparin, IV route, based on patients body weights (UI/kg);Protamin administration |
39 |
Effects of GLP-1 Receptor Agonist Treatment on Pulmonary Function and Quality of Life in Obese Patients With Chronic Obstructive Pulmonary Disease. |
Unknown status |
NCT03466021 |
Phase 4 |
Liraglutide;Placebo |
40 |
Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia |
Unknown status |
NCT01805284 |
Phase 4 |
Linezolid |
41 |
What is the Effects of Incretin on the Blood Pressure and Lipid in Overweight or Obese Diabetes Patients With Masked Hypertension: Liraglutide Plus Mitiglinide Comparing Metformin Plus Mitiglinide or Mitiglinide Alone(BLOOD STUDY) |
Unknown status |
NCT02503943 |
Phase 4 |
"Liraglutide" and "Mitiglinide";"Metformin" and "Mitiglinide";"Mitiglinide" |
42 |
Ultrasonographic Modification of Liver Steatosis and Visceral Fat Induced by Treatment With Losartan and Simvastatin in Hypertensive Normocholesterolemic Obese Patients |
Unknown status |
NCT00669435 |
Phase 4 |
Losartan + Simvastatin;Amlodipine + Simvastatin |
43 |
Structured Exerise Training in Infertile Obese Patients Treated With Assisted Reproductive Techniques: a Randomized Controlled Trial |
Unknown status |
NCT01892111 |
Phase 4 |
|
44 |
The Effects of Cortisol Blockade on Nutritional Sympathetic Nervous System Responsiveness in Overweight and Obese Subjects With Metabolic Syndrome |
Unknown status |
NCT01620684 |
Phase 4 |
metyrapone;placebo |
45 |
Combined Effects of SGLT2 Inhibition and GLP-1 Receptor Agonism on Food Intake, Body Weight and Central Satiety and Reward Circuits in Obese T2DM Patients |
Unknown status |
NCT03361098 |
Phase 4 |
Dapagliflozin 10mg;Exenatide |
46 |
Retroclavicular Approach vs Infraclavicular Approach for Brachial Plexus Block in Obese |
Unknown status |
NCT02990702 |
Phase 4 |
Bupivacaine |
47 |
Oral Tramadol Versus Oral Celecoxib for Post-perineal Repair Analgesia After Spontaneous Vaginal Birth in Obese Women: A Randomised Controlled Trial |
Unknown status |
NCT03694873 |
Phase 4 |
Tramadol Hydrochloride;Celecoxib 200mg |
48 |
The Effect of TRADJENTA ® (LINAGLIPTIN) on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects |
Unknown status |
NCT02372630 |
Phase 4 |
Linagliptin;Placebo |
49 |
Double-blind and Placebo-controlled Study on Intervention Effect of n-3 Fatty Acids on Glucose and Lipid Homeostasis Disorders in Obese/Diabetic Populations |
Unknown status |
NCT03708887 |
Phase 4 |
Low dose omega-3 fatty acid supplementation;High dose omega-3 fatty acid supplementation;Control drug |
50 |
The Use of Antimicrobial Gauze in Pregnant Women Undergoing C-section With BMI >40 to Decrease Wound Complications by 6 Weeks postpartum--a Small Feasibility Study |
Unknown status |
NCT02882360 |
Phase 4 |
|
Inferred drug relations via
UMLS
71
/
NDF-RT
51
:
Benzphetamine
Benzphetamine hydrochloride
Dexfenfluramine
Dexfenfluramine Hydrochloride
Diethylpropion
Diethylpropion Hydrochloride
Fenfluramine
Fenfluramine Hydrochloride
lorcaserin
lorcaserin hydrochloride
Mazindol
Methamphetamine
orlistat
|
phendimetrazine
PHENDIMETRAZINE HYDROCHLORIDE
phendimetrazine tartrate
Phenmetrazine
Phenmetrazine Hydrochloride
Phentermine
Phentermine Hydrochloride
PHENTERMINE RESIN
Phenylpropanolamine
Phenylpropanolamine Hydrochloride
sibutramine
SIBUTRAMINE HYDROCHLORIDE
|
|